Company Encyclopedia
View More
name
PetVivo
PETV.US
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc.
1.391 T
PETV.USMarket value -Rank by Market Cap -/-

Financial Score

22/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking93/174
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-420.98%E
    • Profit Margin-673.99%E
    • Gross Margin72.56%A
  • Growth ScoreA
    • Revenue YoY45.45%A
    • Net Profit YoY-11.90%D
    • Total Assets YoY65.00%A
    • Net Assets YoY922.30%A
  • Cash ScoreB
    • Cash Flow Margin-14.60%D
    • OCF YoY45.45%A
  • Operating ScoreD
    • Turnover0.33D
  • Debt ScoreA
    • Gearing Ratio20.45%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    PetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore" | PETV Stock News

    PetVivo.ai, an AI-powered veterinary platform, launched a video explainer instead of a traditional press release to clearly demonstrate its two-sided ecosystem. The video explains how the platform connects pet parents with veterinary practices using 10 specialized AI agents. This approach aims to simplify understanding and highlight the platform's benefits. PetVivo Holdings focuses on innovative medical devices for companion animals, leveraging human therapies for quicker market entry. The company has a robust product pipeline and a portfolio of patents protecting its technologies.

    StockTitan·
    US
    PETV
    -4.92%
    StockTitan·
    US
    PETV
    -4.92%

    Digital Landia + Influencer Hero Are Launching 20% Lifetime Commission Program That Creates Self-Growing System: More App Users in Your City = More Value for Local Vets = Vets Become Brand Ambassadors = Even More App Users

    Digital Landia Holding Corp has launched AgenticPet, an invite-only beta program offering a 20% recurring commission for pet influencers. Partnering with Influencer Hero, the initiative aims to leverage influencers to drive B2C and B2B growth. The program targets the $140 billion global pet care market, offering specialized AI agents and exclusive technology for PetVivo Holdings' veterinary clinics. The launch is set for December 12, 2025, with the first 100 creators receiving a 25% commission for the first three months.

    Acceswire·
    US
    PETV
    -4.92%
    Acceswire·
    US
    PETV
    -4.92%

    PetVivo Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-89%

    PetVivo Holdings, Inc. has launched PetVivo.ai, an AI platform that reduces veterinary client acquisition costs by 50-89%, offering a customer acquisition cost of $42.53 compared to the typical $80-$400. The platform uses nine AI agents to generate leads at $3 per pet parent and convert them into customers. This strategic move transitions PetVivo from medical device sales to a high-margin AI SaaS model, targeting significant market growth and valuation re-rating.

    fidelity·
    US
    PETV
    -4.92%
    fidelity·
    US
    PETV
    -4.92%

    New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST

    New to The Street Show #702 airs today on Bloomberg at 6:30 PM EST, featuring interviews and business updates from companies like Roadzen, NRx Pharmaceuticals, Aeries Technology, CISO Global, and Acurx Pharmaceuticals. The show is supported by commercials from Synergy CHC, Sustainable Green Team, Laser Pharmaceuticals, and PetVivo. New to The Street is a leading financial media brand providing national TV, digital, and outdoor exposure for public companies.

    Acceswire·
    US
    CISO
    +1.93%
    US
    ACXP
    -3.48%
    US
    NRXP
    +8.72%
    Acceswire·
    US
    CISO
    +1.93%
    US
    ACXP
    -3.48%
    US
    NRXP
    +8.72%

    PetVivo Holdings Inc. Files Initial Beneficial Ownership Statement for Director Joshua David Ruben

    PetVivo Holdings Inc. has filed a Form 3 with the U.S. SEC, naming Joshua David Ruben as a beneficial owner in his role as Director. This filing is accessible via the SEC's EDGAR system. The information is provided by Public Technologies and is for informational purposes only, not as financial or legal advice.

    Reuters·
    US
    PETV
    -4.92%
    Reuters·
    US
    PETV
    -4.92%
    © 2025 Longbridge｜Disclaimer